Toujing Life: Six medical device registration applications accepted by the Shanghai Municipal Medical Products Administration.

Toujing Life announced that the company and its holding subsidiary, Maishi Biotechnology, have had six medical device registration applications accepted by the Shanghai Municipal Drug Administration. Among them, the company has applied for four Class II in vitro diagnostic reagents for the auxiliary diagnosis of Alzheimer's disease, while Maishi Biotechnology has applied for two reagents for the auxiliary diagnosis of hormonal disorders and evaluation of fat-soluble vitamins, respectively. The applications are currently in the acceptance stage, and further technical review processes are required. The acceptance of these applications will have no impact on recent performance, and whether they will be approved remains to be determined by the final review conclusions.